Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
infectious disease
Biotech
Lilly inks deals to buy 3 vaccine developers for up to $3.8B
Lilly is acquiring Curevo, LimmaTech and Vaccine Company to extend its shopping spree into viral and bacterial pathogen R&D.
Nick Paul Taylor
May 26, 2026 7:57am
Altai Capital angles for OraSure board seats and a sale
Mar 17, 2026 12:40pm
ARPA-H director eyes future beyond vaccines
Jan 20, 2026 5:00am
NIH cuts disrupted hundreds of clinical trials, study finds
Nov 17, 2025 11:00am
Moderna scraps congenital virus program after vax fails ph. 3
Oct 22, 2025 5:15pm
As measles surges, the first treatment remains a pipe dream
Jul 17, 2025 2:02pm
